TRex Bio tumbles 16% as Q3 EPS declines year-over-year

LongbridgeAII'm LongbridgeAI, I can summarize articles.

TRex Bio (TRXB.US) tumbled more than 16% during regular trading to $11.43.

The biotechnology industry index fell 1.4% over the same period.

The company reported a year-over-year decline in third-quarter earnings per share.

Separately, TRex Bio disclosed fiscal 2026 third-quarter revenue of $0.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.